Denosumab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH4019
Add to Compare
Rating:
100 % of 100
$306.00
Add to Wish List

Bulk Denosumab Biosimilar - Research Grade

Product Specific Citations:

Pape et al. RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model. Journal of Tissue Engineering (2022). 

Product Benefits:

ichorbio's Denosumab Biosimilar - Research Grade is manufactured in a cGMP compliant facility.

Size:

ichorbio's research grade denosumab biosimilar is available in the following sizes: 5mg, 10mg, 20mg, 50mg, 100mg ichorbio regularly manufactures bulk multi-gram amounts of our denosumab biosimilar - please contact us for pricing.

Target:

RANKL

Clone:

n/a

Isotype:

IgG2

Other Names:

Tumor necrosis factor ligand superfamily member 11, Tnfsf11, Osteoclast differentiation factor, ODF, Osteoprotegerin ligand, OPGL, Receptor activator of nuclear factor kappa-B ligand, TNF-related activation-induced cytokine, TRANCE, CD254, Rank Ligand

Host:

Humanized

Species Reactivity:

Human

Specificity:

Detects human RANK Ligand.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background:

Denosumab biosimilar is a human IgG2 monoclonal antibody that binds to human RANKL. Denosumab has an approximate molecular weight of 147 kDa and is produced in genetically engineered mammalian (Chinese hamster ovary) cells.

Concentration:

1.0 - 5.0 mg/ml

Formulation:

Sterile, clear, colorless to pale yellow, preservative-free solution, containing acetic acid, poly Sorbate 20 and sorbitol, pH 5.2. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

Endotoxin:

≤ 0.75 EU/mg as determined by the LAL method

Storage:

Denosumab Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

Applications:

Functional Assays

Application Notes:

Each investigator should determine their own optimal working dilution for specific applications.

Use: ichorbio's denosumab biosimilar is for research use only (RUO).

Isotype Control:

Bulk Human IgG2 Isotype Control (IB2) [ICH2255]

More Information
Concentration 7.52mg/ml
isotype IgG2
Host Humanized
Write Your Own Review
You're reviewing:Denosumab Biosimilar - Research Grade
Your Rating
Who Viewed This Also Viewed
Bulk Anti-Human HLA-DR (L243) Antibody
Bulk Anti-Human HLA-DR (L243) Antibody
$390.00 - $2,885.00
Anti-Mouse H-2Db (B22/249) In Vivo Antibody - Low Endotoxin
Anti-Mouse H-2Db (B22/249) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Tabalumab Biosimilar - PE Research Grade
Tabalumab Biosimilar - PE Research Grade
$255.00
Narlumosbart Biosimilar - Research Grade
Narlumosbart Biosimilar - Research Grade
$695.00 - $19,500.00
Anti-PD-1 (RMP1-14) 5mg/ml
Anti-PD-1 (RMP1-14) 5mg/ml
$300.00 - $2,160.00
Human IgG1 Isotype Control S239D/I332E
Human IgG1 Isotype Control S239D/I332E
$306.00 - $5,100.00
Anti-Mouse EpCAM (G8.8) In Vivo Antibody - Low Endotoxin
Anti-Mouse EpCAM (G8.8) In Vivo Antibody - Low Endotoxin
$390.00 - $2,885.00
Epcoritamab Biosimilar - Research Grade
Epcoritamab Biosimilar - Research Grade
$357.00 - $19,500.00
Inotuzumab Biosimilar - Research Grade (ICH5316)
Inotuzumab Biosimilar - Research Grade (ICH5316)
$306.00 - $19,500.00
Ipilimumab Biosimilar - Research Grade
Ipilimumab Biosimilar - Research Grade
$306.00 - $19,500.00
Back to Top
Related Products